1. Urban BA, Fishman EK, Goldman SM, Scott WW, Jones B, Humphrey RL, Hruban RH. CT evaluation of amyloidosis: spectrum of disease. Radiographics 1993; 13:1295-1308.
2. Georgiades CS, Neyman EG, Barish MA, Fishman EK. Amyloidosis: Review and CT manifestations. Radiographics 2004; 24:405-416.
3. Pickford HA, Swenson SJ, Utz JP. Thoracic cross-sectional imaging of amyloidosis. AJR 1997;168:351-355.
4. Smith RR, Hutchins GM, Moore GW, Humphrey RL. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med. 1979: 66:96-104.
5. Utz JP, Swenson SJ, Gertz MA. Pulmonary amyloidosis: Mayo Clinic experience from 1980 to 1993. Ann Intern Med 1996;124:407-413.
6. Thompson PJ, Citron KM. Amyloid and the lower respiratory tract. Thorax 1999;54:444-51.
7. Eder L, Zisman D, Wolf R, Bitterman H. Pulmonary hyertension and amyloidosis – an uncommon association: a case report and review of the literature. J Gen Intern Med. 2007;22(3):416-419.
8. Umeda et al. FDG-PET findings of nodular pulmonary amyloidosis with a long term observation. Nihon Kokuki Gakkai Zasshi. 2007 May:45(5):424-9.
9. Asad S, Aquino SL, Piyavisetpat N, Fischman A. False-positive FDG Positron emission tomography uptake in nonmalignant chest abnormalities. AJR 2004;182:983-989.
10. Ollenberger G, Knight S, Tauro A. False-positive FDG positron emission tomography in pulmonary amyloidosis. Clinical Nuclear Medicine 2004;29(10):657-658.
11. Yadav S, Sharma S, Gilfillan I. Unusual positron emission tomography findings in pulmonary amyloidosis: a case report. J Cardiothorac Surg. 2006;1:32.
12. Webb WR, Muller NL, Naidich DP. High resolution CT of the lung. 3rd Edn. Lippincott, Williams & Wilkins.
13. Gideon GA, Lichtig C, Kaftori JK. Tracheobronchopathia osteoplastica: End stage of primary lung amyloidosis? Chest 1972;61:465-468.